Le, Nhon T.
Kroeger, Zachary A.
Lin, Weijie Violet
Khanani, Arshad M.
Weng, Christina Y.
Article History
Accepted: 19 July 2021
First Online: 1 November 2021
Declarations
:
: NTL: none; ZAK: none; WVL: none; AMK: Adverum, Aerpio, Alcon, Allergan, Dutch Ophthalmic Research Center, Genentech, Inc., Iveric Bio, Kato Pharmaceuticals, Kodiak Sciences Inc., Novartis, Gemini Therapeutics, Graybug, Gyroscope, Opthea, Oxurion, PolyPhotonix, Recens Medical, Regenxbio (consultant); Adverum, Alkahest, Allergan, Allegro, Gemini Therapeutics, Genentech, Inc., Gyroscope, Iveric Bio, NGM pharmaceuticals, Kodiak Sciences Inc., Novartis, Opthea, Ophthotech, Oxurion, Regenxbio, Recens Medical (research support); Allergan, Genentech and Novartis (speaker); CYW: Alcon, Allergan/AbbVie, Alimera Sciences, Novartis, Genentech, Regeneron, REGENXBIO, Dutch Ophthalmic Research Center (consultant).